Condition: Predictive Cancer Model · Pathologic Complete Response · Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
The goal of this observational study is to establish a dynamic multi-omics integration model for predicting pathological complete response (pCR) after neoadjuvant treatment in locally advanced (T3-4NxM0) rectal cancer, providing support for subsequent patient selection for the watch-and-wait strategy. The main question it aims to answer is: What is the predictive value of this model to assess individual achievement of pathological complete response (pCR) after neoadjuvant treatment? Eligible patients will be prospectively enrolled, and the clinical features of their pre-neoadjuvant treatment, during-treatment, and post-treatment preoperative will be collected and annotated.
This description comes directly from the study's public registry record.
Jun Huang · +86-13926451242 · huangj97@mail.sysu.edu.cn
Meijin Huang · +86-13924073322 · meijinhuang3@163.com
Always discuss trial participation with your own doctor first.
| The Sixth Affiliated Hospital, Sun Yatsen University | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06364371